Chemistry (relationship)

AeroRx Partners with HCmed to Develop a Nebulized LABA/LAMA Combination Solution for the Treatment of Chronic Obstructive Pulmonary Disease

Retrieved on: 
Monday, October 3, 2022
Solution, Chronic obstructive pulmonary disease, Technology, CEO, CDRO, Chemistry (relationship), Partnership, LLC, Therapy, Quality of life, LABA, Asthma, Patient, COPD, Organization, Population, Pharmaceutical industry

(AeroRx) and HCmed Innovations Co., Ltd. (HCmed) have initiated a collaboration, introducing a LABA/LAMA combination solution for delivery with a breath-actuated nebulizer.

Key Points: 
  • (AeroRx) and HCmed Innovations Co., Ltd. (HCmed) have initiated a collaboration, introducing a LABA/LAMA combination solution for delivery with a breath-actuated nebulizer.
  • This collaboration sets forth the framework by which both companies will work together to develop a new nebulized combination formulation for the treatment of chronic obstructive pulmonary disease (COPD).
  • AeroRx is currently developing the first nebulized LABA/LAMA combination solution, which could benefit 7-19% of the COPD population.
  • Jason Cheng, CEO and founder of HCmed, mentioned, "We are excited to announce our partnership with AeroRx.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Coinbase, Carvana, Kiromic, and LifeStance and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, October 3, 2022
The Wall Street Journal, IND, Offering, COVID-19, Complaint, Policy, NASDAQ, News, Letter, Defendant, Immunotherapy, Compliance, IPO, Register, Life, Bloomberg, Chemistry (relationship), Risk, Patient, Goldman Sachs, Mental health, Physician, SEC, Lists of schools in England, Twitter, FDA, Bankruptcy, Kirom Bukhoroi, Prospectus, GLOBE, Company, Armstrong, Documentation, Workplace, NYSE, Public offering, Shareholder, Cryptocurrency, Security (finance), Audit, Pharmaceutical industry, Animal, P.C, Coinbase, Carvana

The Class Period begins on April 14, 2021, to coincide with the Companys initial listing of common stock on the NASDAQ (the Direct Listing).

Key Points: 
  • The Class Period begins on April 14, 2021, to coincide with the Companys initial listing of common stock on the NASDAQ (the Direct Listing).
  • However, the truth began to emerge on May 10, 2022, when Coinbase filed its first quarter 2022 financial report with the SEC.
  • For more information on the LifeStance class action go to: https://bespc.com/cases/LFST
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

CARVANA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Carvana Co. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, October 1, 2022
Legal, Professional Services, Risk, NYSE, News, P.C, Person, Lists of schools in England, District, Documentation, Jeanne Eagels, Court, Telephone, District court, Chemistry (relationship), Security (finance), Carvana

Investors have until October 3, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until October 3, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • On June 24, 2022, Barrons published an article entitled Carvana Sought to Disrupt Auto Sales.
  • On this news, Carvanas share price fell approximately 21% over the next two trading days, damaging investors.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Muscular Dystrophy Association Celebrates the Approval of Relyvrio from Amylyx for the Treatment of ALS

Retrieved on: 
Friday, September 30, 2022
Motor neuron, Disability, Riluzole, Muscle, Chemistry (relationship), Upper respiratory tract infection, Muscular Dystrophy Association, Twitter, MDA, FDA, Oxidative stress, Diarrhea, Neurodegeneration, Hope, Muscle weakness, LinkedIn, Edaravone, Neuromuscular disease, Patient, Disorder, Life expectancy, Diagnosis, Drug development, Amyotrophic lateral sclerosis, Degenerative disease, Muscular dystrophy, TikTok, ALS, Research, US Food Sovereignty Alliance, Abdominal pain, Nausea, Multimedia, HIV disease progression rates, View, Toxicity, Pharmaceutical industry, Aluminium, Facebook, Instagram

NEW YORK, Sept. 29, 2022 /PRNewswire/ -- The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of sodium phenylbutyrate/taurursodiol (Relyvrio) for the treatment of amyotrophic lateral sclerosis (ALS), on September 29.

Key Points: 
  • NEW YORK, Sept. 29, 2022 /PRNewswire/ -- The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of sodium phenylbutyrate/taurursodiol (Relyvrio) for the treatment of amyotrophic lateral sclerosis (ALS), on September 29.
  • MDA was proud to support the original testing in ALS of sodium phenylbutyrate, one of the two elements in Relyvrio.
  • At present there are two drugs that come in different formulations that are approved by the FDA for the treatment of ALS.
  • Muscular Dystrophy Association (MDA) is the #1 voluntary health organization in the United States for people living with muscular dystrophy, ALS, and related neuromuscular diseases.

Global Pharmaceutical Filtration Market Report 2022: Nanofiltration Technology Adoption Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 29, 2022
Other Manufacturing, Medical Devices, Medical Supplies, Manufacturing, Biotechnology, Health, Pharmaceutical, Other Science, Science, Eric Haze, Ultrafiltration, Filtration, Filter, Gas, Sterilization, Heat, Chemistry (relationship), Pressure, Solution, Sewage, Wine

The "Pharmaceutical Filtration: Global Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pharmaceutical Filtration: Global Markets" report has been added to ResearchAndMarkets.com's offering.
  • The usual objective is a sparkling liquid that is free of amorphous or crystalline precipitates, colloidal hazes or insoluble liquid drops.
  • The term "filtration" is defined as the process in which particles are separated from a liquid by passing the liquid through a permeable material.
  • Sterile filtration of bulk drug solution prior to an aseptic crystallization process eliminates the possibility of organisms being occluded within crystals.

Shaklee Enters New Beauty & Wellness Category with Launch of Clean Anti-Aging Body Care Line

Retrieved on: 
Thursday, September 29, 2022
Cosmetics, Health, Carbon, Safety, Coconut oil, Chemistry (relationship), Ageing, Hyaluronic acid, Yale Law School, Harvard Business School, Nicotinamide, Genetically modified organism, Environment, Sulfate, Harvard University, Silicone, Midwest Universities Consortium for International Activities, CEO, Yale University, Paraben, Collection, Collagen, World Economic Forum, Skin, Multimedia, Yale College, Antioxidant, University council, Pharmaceutical industry, Online shopping, Shaklee, Facebook, Instagram

PLEASANTON, Calif., Sept. 29, 2022 /PRNewswire/ -- Shaklee, a leading wellness company, announced today the introduction of its clean, anti-aging body care collection – Shaklee Body. Backed by the brand's foundation of clinically proven results and its pioneering history in nutrition, Shaklee Body is designed to deliver nutrition for the skin from the outside in.

Key Points: 
  • PLEASANTON, Calif., Sept. 29, 2022 /PRNewswire/ -- Shaklee , a leading wellness company, announced today the introduction of its clean, anti-aging body care collection Shaklee Body.
  • Shaklee Body is a highly effective, clean, and accessible anti-aging solution for those who are looking to improve the health of their skin,"said Roger Barnett, Chairman and CEO, Shaklee Corporation.
  • "At Shaklee, we've been pioneers in the nutrition category for more than 65 years and are proud to bring our scientific and natural approach to wellnessand create a clinically tested, anti-aging body care line that embraces the highest level of clean beauty standards."
  • Shaklee Body exceeds clean beauty standards, formulating without more than 2,500 ingredients that are potentially harmful to our personal health or the health of the environment.

Address Oxidative Stress with Greenfilled's Uniquely Potent Supplements

Retrieved on: 
Thursday, September 29, 2022
Nitrogen, Health, Rest, Chemistry (relationship), Oxygen, Ageing, Oxidative stress, UV, ROS, Protein, Quality of life, Cell, Research, DNA, SOD, Aquaculture

FORT LAUDERDALE, Fla., Sept. 29, 2022 /PRNewswire/ --Oxidative stress is a basic bodily concern that everyone deals with.

Key Points: 
  • FORT LAUDERDALE, Fla., Sept. 29, 2022 /PRNewswire/ --Oxidative stress is a basic bodily concern that everyone deals with.
  • ROS are normal, as is the oxidation process, but an imbalance caused by external factors, like UV exposure or pollutants, can lead to oxidative stress.
  • The health and wellness brand has created a line of supplements that utilize a key ingredient, TetraSOD, to combat oxidative stress.
  • TetraSOD is harvested and freeze-dried on site with no additives, too, making it a clean, strong, and effective natural solution to oxidative stress."

Ursolic Acid Global Market Report 2022: A $10.92 Million Market by 2026 - Long-term Forecast to 2031 with Focus on 25% Ursolic Acid, 50% Ursolic Acid, 90% Ursolic Acid, & 98% Ursolic Acid - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 29, 2022
Chemicals, Plastics, Manufacturing, Xi, Degenerative disease, Chemistry (relationship), Rash, Prevalence, Blood, Organization, Mammal, Growth, Industry, Capsule, Cardiovascular disease, Spermatogenesis, Heart rate, Cardiology, Food, Death, Research, Urine, Nausea, CVD, Cosmetics, Plant, Drink, Disease, Renewable energy, Forbes

The main types of ursolic acid include 25% ursolic acid, 50% ursolic acid, 90% ursolic acid, 98% ursolic acid, and other types.

Key Points: 
  • The main types of ursolic acid include 25% ursolic acid, 50% ursolic acid, 90% ursolic acid, 98% ursolic acid, and other types.
  • Thus, the increasing penetration of ursolic acid in the cosmetic industry drives the growth of the ursolic acid market.
  • The side effects of ursolic acid are expected to hamper the growth of the ursolic acid market in the forecast period.
  • Therefore, the side effects of ursolic acid hinder the growth of the ursolic acid market.

Enforcement Notice - Hearing - IN THE MATTER OF Paul Maurice -Review Requested

Retrieved on: 
Wednesday, September 28, 2022
Enforcement, Chemistry (relationship), Property management, Financial adviser, IIROC

All information about disciplinary proceedings relating to current and former member firms is available in the Enforcement section of the IIROC website.

Key Points: 
  • All information about disciplinary proceedings relating to current and former member firms is available in the Enforcement section of the IIROC website.
  • Background information regarding the qualifications and disciplinary history, if any, of advisors currently employed by IIROC-regulated firms is available free of charge through the IIROC AdvisorReport service.
  • Information on how to make investment dealer, advisor or marketplace-related complaints is available by calling 1 877 442-4322.
  • IIROC is the pan-Canadian self-regulatory organization that oversees all investment dealers and their trading activity in Canada's debt and equity markets.

CARVANA CO. (NYSE: CVNA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Carvana Co. (NYSE: CVNA)

Retrieved on: 
Tuesday, September 27, 2022
Securities Exchange Act of 1934, Advertising, Risk, NYSE, NEW, Company, News, Investment, Lists of schools in England, District, Documentation, Court, District court, GLOBE, Chemistry (relationship), Labour government, The Legal 500, Security (finance), Online gambling, Tobacco, Carvana

NEW YORK, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Carvana Co. (“Carvana” or the “Company”) (NYSE: CVNA) between May 6, 2020 and June 24, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the District of New Jersey and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Carvana purports to be, along with its subsidiaries, an e-commerce platform for buying and selling used cars in the United States.
  • Plaintiff alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and compliance policies.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.